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There is a large body of literature demonstrating an important role of mast cells in adaptive and innate immunity. The distribution
of mast cells in the skin varies in diﬀerent parts of the body. It is well known that mast cells are important for eﬀector functions
of classic IgE-associated allergic disorders as well as in host defense against infective agents and inﬂuence the manifestation of
autoimmune diseases. We aimed to quantify mast cells in ﬁve common dermatoses and compare them statistically with respect
to the immunostains. We retrieved paraﬃn-embedded tissue sections from the archives of the Pathology Department at the UF,
Jacksonville, for ﬁve cases with each of the above diagnosis from the last three years. We performed CD-117 and tolidine blue
stains on each one of them. The presence or absence of mast cells was evaluated and quantiﬁed. We observed that, in the skin,
mast cells are mainly located close to the vessels, smooth muscle cells, hair follicles, and nerve ending. Our study showed that the
mast cell distribution pattern is diﬀerent across the two methods of staining for the ﬁve aforesaid dermatoses. The other important
observation was the dendritic morphology of the mast cells.
1.Background
Dermatoses are a broad term, which includes any skin dis-
eases, which are not characterized by neoplasm. Mast cells
were ﬁrst described based on staining of cytoplasmic gran-
ules, by Ehrlich in 1877 [1] .T h e r ei sal a r g eb o d yo fl i t e ra t u r e
indicating an important role of mast cells in adaptive and
innate immunity. The distribution of mast cells in the skin
varies in diﬀerent parts of the body. They are usually in
higher number at the extremities and lower at the trunk [2].
Within the skin, the number of mast cells is 10-fold in the
upper dermis as compared to the subcutis. However, there is
no diﬀerence between gender and age groups [3]. It is well
known that mast cells are important for eﬀector functions
of classic IgE-associated allergic disorders as well as in host
defenseagainstparasites,viruses,andbacteriaandalsoinﬂu-
ence the manifestation of autoimmune diseases including
psoriasis, rheumatoid arthritis (RA), or bullous pemphigoid
(BP). In the skin mast cells are mainly located close to the
vessels, smooth muscle cells, hair follicles, and nerve ending
[3]. Mast cells are derived from hematopoietic progenitor
cells and mature in the local tissue where they reside.
Once they mature in the tissues, they are associated with
a partly tissue-speciﬁc pattern of mediators in their gran-
ules. Based on types of proteinases, human mast cells can
be divided into mainly tryptase- and -chymase- (MCTC-),
tryptase- (MCT-), or chymase- (MCC-) containing sub-
types. MCTC mast cell type predominates in the dermis
of the skin and submucosa, whereas MCT mast cell type
predominates in the lung and bowel submucosa [4, 5].
The mast cell number, distribution, and functions change
in diﬀerent subtypes of dermatoses. There is not much
published data regarding the analysis and quantiﬁcation of
mastcellsintheﬁvemostcommondermatoses,thatis,lichen2 ISRN Dermatology
Table 1: Participant characteristics by disease. There were 24 people in the study (15 females and 9 males).
Characteristic Psoriasis Lichen simplex
chronicus Lupus Lichen
planus
Allergic/
nummular/insect Total
Age, mean ± SD 37.2 ±11.84 8 .3 ±10.94 7 .2 ±15.55 1 .6 ±13.61 9 ±11.24 6 .6 ±12.7
Gender
Female 3 2 5 2 3 15 (62.5%)
Male 2 2 0 3 2 9 (37.5%)
simplex chronicus, Psoriasis, lichen planus, lupus, and insect
bite/allergic contact dermatitis/nummular dermatitis. Since
it is usually not possible to diﬀerentiate insect bite, allergic
contact dermatitis, and nummular dermatitis based on his-
tology, we have combined them together in one category.
2.MaterialsandMethod
We retrieved formalin ﬁxed-paraﬃn-embedded tissue sec-
tions from the archives of the pathology department at the
UF Shands Jacksonville for ﬁve cases with each of the above
diagnosis from the last three years (2008 to 2011). These
had been processed for routine histology using standard
protocols. Brieﬂy, they were ﬁxed in 5% buﬀered formalin,
and the sections were stained with hematoxylin and eosin
dyes (H&E), CD-117 (C-kit), and Toluidine blue. Formalin
was used as a ﬁxative because formalin-ﬁxed tissue yields the
same results of mast cells compared to Carnoy’s ﬂuid. The
cases were chosen based on the diagnosis made earlier, using
the Co-path software. We performed both CD-117 (C-Kit)
and toluidine blue stains on each one of them. The presence
or absence of mast cells was evaluated by two pathologists
at 40x magniﬁcation and when present was quantiﬁed. Sev-
eral ﬁelds (minimum 5 ﬁelds) of 40x magniﬁcation were
evaluated, and a mean was determined for each of the two
stainingmethods.Wedidacomparativeanalysisformastcell
quantiﬁcation across these diﬀerent diagnoses.
3.StatisticalAnalysis
Due to small number of casesin each category of diseases, we
used a nonparametric test, the Mann-Whitney U test (and
reportedthemedianstogetherwith25thand75thpercentile)
to determine whether there was a signiﬁcant diﬀerence bet-
ween the staining methods (CD-117 (C-kit) v/s toluidine
blue) for revealing the mast cells. We considered a P value
of <0.05 to be statistically signiﬁcant.
4. Results
There were a total of 25 patients in the study (15 females and
10 males). The distribution of gender was variable across all
the disease entities except lupus, where all the patients were
female (see Table 1). Also, in the category of lichen simplex
chronicus, we had to eliminate one patient (male) as the CD-
117 (C-kit) and toluidine blue stains were not adequate for
interpretation due to minimal dermal tissue. The mean age
of subjects plus/minus standard deviation was 37.2±11.8f o r
Table 2: Mast cells. It shows the outcome variable—the number
of mast cells. Overall, the distribution of mast cells is diﬀerent
across the two methods (P<. 0001). The median number of
mast cells revealed using C-Kit method was 17.5 compared to the
median number of mast cells revealed using T-Blue method. The
distribution of mast cells is same across the two methods for lichen
simplex chronicus (P = 0.110).
Characteristic Median (p25, p75)1 P value2
Group
C-Kit 17.5 (11.8; 22.5)
T-Blue 3.8 (2.5; 7.0) <.0001∗
Psoriasis
C-Kit 16.5 (16.0; 20.5)
T-Blue 2.5 (1.0; 4.0) 0.012∗
Lichen simplex chronicus
C-Kit 14.3 (10.0; 35.0)
T-Blue 7.8 (6.0; 12.8) 0.110
Lupus
C-Kit 12.5 (6.0; 17.5)
T-Blue 5.5 (3.5; 6.0) 0.024∗
Lichen planus
C-Kit 22.5 (20.0; 22.5)
T-Blue 3.5 (0.5; 7.5) 0.036∗
Allergic/nummular/insect
C-Kit 17.5 (15.0; 22.5)
T-Blue 3.0 (2.5; 3.0) 0.009∗
1p25 represents the 25th percentile; p75 represents the 75th percentile.
2Mann-Whitney U test.
∗indicates signiﬁcance at 0.05 level of signiﬁcance.
psoriasis,48.3±10.9forlichensimplexchronicus,47.2±15.5
for lupus, 51.6 ± 13.6 for lichen planus, and 19 ± 11.2f o r
insect bite/allergic contact dermatitis/nummular dermatitis,
respectively. The mean age across all these disease entities
was 46.6 ± 12.7 (see Table 1). According to the published
literature, lichen simplex chronicus, lichen planus, or lupus
is observed more commonly in females compared to males
while psoriasis aﬀects men and women equally. There is
poor epidemiologic data regarding insect bite/allergic con-
tact dermatitis/nummular dermatitis. Our study somewhat
supports this observation except for lichen planus; however,
the sample size is small to comment on this. Results are
expressed as median. Overall, the distribution of mast cells is
diﬀerent across the two methods (P<. 0001) (see Table 2).ISRN Dermatology 3
Figure 1: Psoriasis with mast cells next to the capillary vessel. H&E,
40x.
Figure 2: Lichen simplex showing mast cells in the vicinity of a
capillary vessel. H&E, 40x.
The median number of mast cells revealed using CD-117
(C-Kit) method was 17.5 compared to the median number
of mast cells revealed using toluidine blue method which
was 3.8. There was no statistical signiﬁcance between the
two methods for lichen simplex chronicus (P = 0.110).
With the other disease entities, the P value was statistically
signiﬁcant. (psoriasis: P value ≤ 0.0012, lupus: P value =
0.024, lichen planus: P value = 0/036, insect bite/allergic
contact dermatitis/nummular dermatitis: P value = 0.009)
distribution (see Figure 2).
4.1. Histological Examination
4.1.1. Morphology. Mast cells were found throughout the
dermis and were concentrated in the vicinity of vessels and
skin appendages (Figures 1 and 2). They had a blue rounded
nucleus, and their granules were metachromatically stained
reddish purple with toluidine blue and brown with CD-117
(C-kit) stain (Figures 3 and 4). No mast cells were seen in
the epidermis. C-kit (CD 117) is expressed by hematopoietic
stem cells and is maintained during myeloid diﬀerentiation.
Figure 3: Mast cells stained with toluidine blue showing intracyto-
plasmic granules 40x.
Figure 4: Mast cells stained with C-kit (CD117) next to the vessel
40x.
It is thus an early marker for mast cell precursors. Mast cells
continue to express CD-117 (C-kit) throughout the lifetime
of the cell, unlike most other cells (including basophils),
which lose this marker during their development.
4.1.2. Evaluation of Fixative and Staining. Several studies
have been done evaluating the ﬁxative used for histology.
Fixation in formaldehyde is superior to Carnoy’s ﬁxative as
per Damsgaard TE and colleagues [6]. We used 2 methods
of stain, that is, CD-117 (C-kit) and toluidine blue. The two
methods reveal diﬀerent distribution with a P value of less
than 0.0001.
4.1.3. Quantiﬁcation of Mast Cells. The number of mast cells
stained with CD-117 (C-kit) and toluidine blue stains in
biopsies from patients is shown in Table 2.Am a n u a lc o u n t
by two pathologists under 40x magniﬁcation was performed.
There were greater numbers of mast cells in lesional skin
which were stained by CD-117 (C-kit) compared to the tolu-
idine blue. The P value was signiﬁcant across all the disease4 ISRN Dermatology
(a) (b)
Figure 5: C-Kit (CD117) staining reveals the dendritic features of mast cells 40x.
entities using CD-117 (C-kit) and toluidine blue stain except
Lichen simplex chronicus where there was no signiﬁcant
diﬀerence in the two stains for mast cell evaluation.
5. Discussion
Mast cells are well known as eﬀector cells of IgE-mediated
allergic reactions. The important functions of mast cells in
diﬀerent diseases including innate immunity and the induc-
tion and regulation of adaptive immune responses have
been reported [7–11]; however, their role in pathogenesis
of the dermatological diseases is not fully understood.
There is evidence of increase in the number of mast cells
with degranulation in contact dermatitis. It is suggested
that through the production of mediators, cytokines, and
chemokines, they contribute in the pathogenesis of the
diseases. We decided to quantify the mast cells to understand
their signiﬁcance and role as the eﬀectorin these 5 cutaneous
diseases.
Mast cells are identiﬁable on H&E staining, but because
of compar able morphology with other mononuclear cells,
such as monocytes, histiocytes, lymphocytes, and nevome-
lanocytes, they may require special staining for veriﬁcation.
Diﬀerent staining like Giemsa, toluidine blue, and Leder
stain have been used, but immunohistochemistry is now
often employed using C-kit (CD 117). We observed that, in
the skin, mast cells are mainly located close to the vessels,
smooth muscle cells, hair follicles, and nerve ending similar
to the previously published data.
Our study revealed that the mast cell distribution pattern
is diﬀerent across the two methods of staining (CD-117 (C-
kit) and toluidine blue) for the ﬁve aforesaid dermatoses.
CD-117 (C-kit) staining in psoriasis, lupus, lichen planus,
and insect bite/allergic contact dermatitis/nummular der-
matitis is statistically signiﬁcant in revealing the mast cells
in skin biopsies compared to toluidine blue. The other im-
portant observation was the dendritic nature of the mast
cells (Figures 5(a), 5(b) and 6) .S o m ec e l l sh a v eo n l ys l e n d e r
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processes, whereas other cells have several long processes
extending from the cell body. Some of these processes
divide into two or three terminal branches. Our observation
contributes new concepts to the heterogeneity of mast
cells. Hence, human mast cells may vary with respect to
morphologic features such as presence of dendritic processes
as in our observation apart from the mediator contents.
In our understanding, this dendritic morphology may
be due to their common origin from hematopoietic stem
cell. The impact of mast cells on dendritic cell maturation
a n df u n c t i o nh a sb e e ns t u d i e db yD u d e c ke ta l .[ 12]. It was
observed that mast cells primed dendritic cells stimulated
CD4+ T cells to release high levels of cytokines, interferon-
γ (IFN-γ), and interleukin-17 (IL-17). The dendritic cell
migration, maturation, and cytokine release are aﬀected by
thehistamineandtumornecrosisfactor(TNF)releasedfrom
mast cells following an IgE-dependent stimulation.ISRN Dermatology 5
In addition to their role in immunity, mast cells par-
ticipate also in the pathogenesis of ﬁbrotic diseases and are
found to stimulate ﬁbroblast proliferation and collagen syn-
thesis through some ﬁbrotic mediators such as histamine
and tryptase [13]. Studies have revealed that in presence
of degranulated mast cells there was increased synthesis of
type a1(I) procollagen mRNA. Mast cell tryptase stimulated
ﬁbroblast chemotaxis and also stimulated collagen mRNA
synthesis [14]. Other functions of mast cells have been pos-
tulated in the sites of tumor formation around the squamous
cells carcinomas, basal cell carcinomas, and angiosarcomas
[3]. This may be of interest as activated mast cells can
producegrowthfactorsandgrowthanddifferentiationmod-
ulating factors such as IFN-γ, TNF, and vascular endothelial
growth factor (VEGF).
Themastcell-targetingtherapeuticapproachesareunder
developmentfollowingtheidentiﬁcationofspeciﬁcreceptors
on mast cells and elucidation of molecular mechanisms
underlying activation of these cells [15] .T h e s es t u d i e sr e v e a l
a varied roleof mast celland their diagnostic and therapeutic
importance in diﬀerent diseases.
6. Conclusion
The role of mast cells as the “immune ampliﬁers” and the
fact that activated mast cells can produce a broad range of
immune mediators (such as IFN-γ, TNF, VEGF, endothelial
growth factor (EGF), heparin, histamine, and matrix met-
alloproteinase) are of great interest for clarifying the task of
mast cells in diﬀerent diseases, for which quantiﬁcation of
mast cells is one of the initial steps in this pathway. Our study
highlightsasigniﬁcantvariationbetweentheCD-117(C-kit)
and toluidine blue staining pattern for mast cells. Also the
dendritic morphology of mast cells can further be studied
using mast cell-speciﬁc stains like the chymase and tryptase.
Hence-further studies need to be done using mast cell-
speciﬁc immunohistochemical stains in order to quantify
themandfurtherunderstandtheirmorphologyandfunction
in relation to their mediator contents.
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